Magnesium Verla (Magnesium Aspartate Dihydrate)

Magnesium aspartate, the active ingredient in Magnesium Verla, is a mineral supplement presented as an oral formulation for oral use. It helps address magnesium deficiency and supports normal muscle, nerve and cardiovascular function in adults. GNH USA supplies Magnesium Verla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium Verla is a mineral supplement that addresses conditions related to low magnesium status and supports neuromuscular health. - Magnesium deficiency: helps restore normal magnesium concentrations in the body. - Muscle and nerve function: contributes to the maintenance of normal muscle contraction and nerve transmission. - Occasional muscle cramps: may relieve transient cramping episodes associated with low magnesium levels.

Magnesium Verla is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium that can cause cardiac arrhythmia. - Low blood pressure: unexpected hypotension, especially in patients on antihypertensives. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Muscle weakness: marked reduction in muscle strength in rare cases.

When using Magnesium Verla, consider the following safety measures. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor serum magnesium: avoid excessive accumulation during long‑term therapy. - Avoid concurrent high‑dose antacids: they may reduce magnesium absorption. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Magnesium Verla can affect the activity of several other medicines.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may lead to additive electrolyte disturbances. - Antacids containing aluminum or calcium: significantly reduce magnesium absorption. - Bisphosphonates: concurrent use can impair bisphosphonate effectiveness.

Moderate Interactions (Monitor Closely): - Tetracycline or fluoroquinolone antibiotics: magnesium may bind and lower antibiotic bioavailability. - ACE inhibitors or ARBs: combined effect may enhance hypotensive response. - Diabetes medications: magnesium can influence glucose metabolism, requiring closer glycemic monitoring.